プラスミノーゲンアクチベーターインヒビター2
関連文献

“Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes”. Electrophoresis 13 (12):  960–9. (December 1992). doi:10.1002/elps.11501301199. PMID 1286667.
“Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors”. The Journal of Biological Chemistry 265 (17):  9904–8. (June 1990). doi:10.1016/S0021-9258(19)38757-5. PMID 2161846.
“The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes”. The Journal of Cell Biology 111 (2):  783–92. (August 1990). doi:10.1083/jcb.111.2.783. PMC 2116194. PMID 2166055. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2116194/.
“Chromosomal organization and localization of the human urokinase inhibitor gene: perfect structural conservation with ovalbumin”. Genomics 6 (1):  159–67. (January 1990). doi:10.1016/0888-7543(90)90461-3. PMID 2303256.
“Endotoxin-induced production of plasminogen activator inhibitor by human monocytes is autonomous and can be inhibited by lipid X”. Blood 73 (8):  2188–95. (June 1989). doi:10.1182/blood.V73.8.2188.2188. PMID 2471561.
“Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin”. The Journal of Biological Chemistry 264 (10):  5495–502. (April 1989). doi:10.1016/S0021-9258(18)83572-4. PMID 2494165.
“Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells”. Thrombosis and Haemostasis 61 (3):  517–21. (June 1989). doi:10.1055/s-0038-1646626. PMID 2799763.
“Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene”. Biochemical and Biophysical Research Communications 156 (1):  383–8. (October 1988). doi:10.1016/S0006-291X(88)80852-0. PMID 2845977.
“cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta”. The Journal of Biological Chemistry 262 (8):  3718–25. (March 1987). doi:10.1016/S0021-9258(18)61414-0. PMID 3029122.
“Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor”. Proceedings of the National Academy of Sciences of the United States of America 85 (4):  985–9. (February 1988). Bibcode: 1988PNAS...85..985A. doi:10.1073/pnas.85.4.985. PMC 279685. PMID 3257578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC279685/.
“Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells”. Molecular and Cellular Biology 7 (12):  4564–7. (December 1987). doi:10.1128/mcb.7.12.4564. PMC 368144. PMID 3325828. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC368144/.
“Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor”. The Journal of Experimental Medicine 166 (1):  77–94. (July 1987). doi:10.1084/jem.166.1.77. PMC 2188630. PMID 3496414. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188630/.
“Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function”. The Journal of Biological Chemistry 270 (46):  27894–904. (November 1995). doi:10.1074/jbc.270.46.27894. PMID 7499264.
“Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms”. European Journal of Biochemistry 218 (3):  1071–82. (December 1993). doi:10.1111/j.1432-1033.1993.tb18467.x. PMID 7506655.
“Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope”. Experimental Cell Research 217 (1):  65–71. (March 1995). doi:10.1006/excr.1995.1064. PMID 7867722.
“Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease”. Neuroscience Letters 164 (1–2):  233–5. (December 1993). doi:10.1016/0304-3940(93)90899-V. PMID 8152607.
“Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity”. FEBS Letters 323 (3):  279–84. (June 1993). doi:10.1016/0014-5793(93)81357-6. PMID 8388810.
“Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3”. Genomics 43 (3):  321–8. (August 1997). doi:10.1006/geno.1997.4827. PMID 9268635.
“DNase I hypersensitive sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes”. European Journal of Biochemistry 256 (3):  550–9. (September 1998). doi:10.1046/j.1432-1327.1998.2560550.x. PMID 9780231.
“Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta”. The Kobe Journal of Medical Sciences 44 (1):  31–43. (February 1998). PMID 9846056.
PAI-2のRCL、PDB: 2ARR​。